Gå til hovedindhold
Group 3

Brødkrumme

  1. Forside
  2. Forskning
  3. Evaluation of the Photocarcinogenic Potential of Perfluorooctanoic Acid in Mice after Topical and Oral Exposure
  • En
  • Da

Main navigation

    • Vision og formål
    • Organisationen
    • Partnere og samarbejdspartnere
    • Årsrapport
    • Ledige stillinger
    • Hvad er hudkræft?
    • Hyppighed
    • Forebyggelse
    • Undersøgelse og diagnostik
    • Behandlinger
    • Særligt udsatte patienter
    • Guidelines
    • Søgemaskine til hudkræft
  • Nyheder
  • Forskning
  • Team
  • Deltag i kliniske forsøg
  • Presse

Brødkrumme

  1. Forside
  2. Forskning
  3. Evaluation of the Photocarcinogenic Potential of Perfluorooctanoic Acid in Mice after Topical and Oral Exposure
Artikel
2025
Donslund MFS, Granborg JR, Niklas AA, Janfelt C, Sloth JJ, Philipsen PA, Wulf HC, Lerche CM. J Invest Dermatol. 2025 Jun;145(6):1509-1512.e6

Evaluation of the Photocarcinogenic Potential of Perfluorooctanoic Acid in Mice after Topical and Oral Exposure

No abstract available

Flere publikationer

Artikel
2026

Machine-learning-based Phenomapping of Patients with Keratinocyte Carcinoma: Data-driven Subgrouping by Disease Burden, Comorbidities and Socioeconomic Status

Sieborg J, Wenande E, Nielsen ML, Nielsen M, Thein D, Haedersdal M. Acta Derm Venereol. 2026 Aug 13;106.
Artikel
2026

Recurrence of Basal Cell Carcinoma across Different Treatment Modalities: A Nationwide Study with 8 Years of Follow-up and Modelled Prediction

Sieborg J, Wenande E, Egeberg A, Sølvsten H, Lei U, Kjeldsen EW, Haedersdal M. Acta Derm Venereol. 2026 Jul 9;106:0064.
Artikel
2026

Repositioning Non-Ablative Fractional Lasers - Molecular and Histological Insights from a scoping review

Erlich G, Paasch U, Jacobsen K, Haedersdal M, Olesen UH. . J Dtsch Dermatol Ges. 2026 Jul 2. doi: 10.1111/ddg.70487. Online ahead of print.
Group 3

Videncenterets partnere

Privathospitalet Mølholm 
Aalborg Universitetshospital
Bispebjerg Hospital

Genveje og links

  • Privatlivspolitik
  • Om brug af hjemmesiden
  • Kontakt
  • Presse
  • Instagram
  • LinkedIn